dr. tal zaks on the jak2 inhibitor sar302503 in myelofibrosis
Published 11 years ago • 969 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:23
dr. tal zaks on treatments and pathways in myelofibrosis
-
1:21
dr. zaks describes the mechanism of action of sar302503
-
2:22
dr. mesa on the evolving role of jak2 inhibitors in myelofibrosis
-
1:15
dr. tal zaks on patient-reported symptom assessments
-
1:19
dr. srdan verstovsek on jak2 inhibitors as a treatment for myelofibrosis
-
2:06
second-line myelofibrosis treatment – the potential of jak2 inhibitor ns-018
-
6:57
covid-19 challenger: dr. tal zaks
-
14:05
myelofibrosis: emerging jak2 inhibitor combination treatment strategies
-
51:48
world leading geneticist and immunologist josef penninger on potential covid-19 treatment
-
3:10
university acceptance reaction (nus medicine) *dream come true ?!?*
-
18:04
how mrna medicine will change the world | melissa j. moore | ted
-
22:45
myelofibrosis and jak mutations (podcast)
-
10:15
rewriting the genetic code: a cancer cure in the making | tal zaks | tedxbeaconstreet
-
0:35
2nd-generation moderna vaccine opened to all adults | taiwanplus news
-
1:33
dr. mesa on late-stage trials in myelofibrosis
-
0:45
moderna chief reflects on vaccine development
-
0:51
moderna vaccine shows promise as safest and most effective mrna vaccine for older adults
-
4:02
notching in tkr - tayside classification - with examples
-
0:47
watch dr. michael teng explain why the new covid-19 vaccine works
-
4:54
what are the primary ingredients in the moderna and pfizer vaccines? - dr. t
-
20:42
beyond jak2 inhibitors: new targets and new agents
-
1:08
moderna’s coronavirus vaccine shows signs of early progress